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Introduction 
The prevalence of psoriasis within the UK is estimated at 2-3% of population, with at least 30% of 
those developing psoriatic arthritis (PsA) [1]. PsA is an inflammatory arthritis affecting the joints and 
connective tissue and is usually associated with psoriasis [1, 2]. The condition is a long-term causing 
progressive joint damage [1, 3]. The main clinical features include: enthesitis (inflammation at 
tendon/ ligament attachments), dactylitis (digit swelling), spondylitis (inflammatory back pain) and 
inflammation of distal interphalangeal joints [4]. As well as the physical burden of the illness, many 
patients with PsA also experience high levels of anxiety and depression associated with psychological 
distress, which has been shown to remain high even when disease severity is low [3].  
It has been proposed that patients develop representations (lay beliefs) of their illness to make 
sense of, and manage, their condition [2]. Illness representations are based on the Leventhal’s 
common-sense model (CSM), which includes five domains; identity (the label/ diagnosis given to the 
condition and the symptoms), time-line (beliefs about how long the condition might last), 
consequence (beliefs about the consequence of the condition), causal (beliefs about the cause of the 
condition) and control (beliefs about whether the condition can be cured or managed) [5, 6] 
Leventhal suggested that when patients are faced with new symptoms or a diagnosis, they will 
initiate the development of representations that will influence their emotional and behavioural 
coping strategies. Previous research in a range of long-term conditions, including diabetes, chronic 
fatigue syndrome, irritable bowel syndrome and psoriasis, has demonstrated a link between the 
CSM of illness representations and the way in which people make sense of and manage their 
condition [7]. 
 
Although there has been limited research regarding the representations that people with PsA hold 
concerning their condition and how they affect outcomes, the available research suggests that the 
CSM is a useful framework for gaining insight into patients’ responses to PsA and its’ treatment. 
Representations can be informed by a range of sources and influenced by personal and contextual 
factors. As such, they have the potential to be erroneous or unhelpful, with evidence suggesting that 
they can lead to negative coping strategies including, social isolation, alcoholism, and psychological 
distress [3, 6, 8]. Quantitative research has also linked illness representations to poor health related 
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quality of life (QoL) and psychological distress through numerous concerns regarding bodily 
symptoms (identity) and the perceived negative consequences of PsA [2, 9].  
Representations have been shown to impact on patients’ behavioural and psychological responses 
to their condition, for example a perception that the illness is controllable was positively related to 
patients’ self-management, well-being and social functioning[7]. As a consequence, representations 
are important determinants of outcome [2, 7]. 
In a previous qualitative study to identify treatment outcomes important to patients with PsA, 
participants in focus groups discussed minimising harm and burden from the condition and from the 
treatment, alongside reducing the impact and striving to optimise their prognosis [10]. Participants’ 
accounts of their treatment-related decisions and behaviours were set in the context of their 
underlying representations about PsA. Insights into these representations could help clinicians to 
understand patients’ responses to their PsA and their treatment decisions. Furthermore it may also 
help clinicians to identify areas of practice where their input could positively influence patients’ 
representations to aid with self-management and reduce psychological distress. The aim of the study 
was to explore the illness representations of patients with PsA who took part in focus groups to 
discuss important outcomes of treatment. 
 
Method 
A secondary analysis of eight focus groups held across five hospital sites (three in the Southwest of 
England, one in the West Midlands and one in West Yorkshire) and comprising 41 participants was 
undertaken. This study was approved by the National Research Ethics Service Committee North 
West-Haydock (reference 15/NW/0609) [10].  In the original study, data were collected between 
November 2015 and April 2016 and participants from a range of phenotypes and domains of disease 
activity were invited to participate: men=20 and women=21; mean age=58 years (SD 11.4); mean 
disease duration=9 years (SD 8.3); mean HAQ=1 (SD 0.7). Further details relating to the design, 




A deductive, theory-driven thematic analysis was conducted using the CSM as a framework [11,12]. 
The aim of the analytical process was to support, extend, or challenge the extent to which the CSM 
made sense of, and provided a comprehensive account of, participants’ PsA and treatment related 
representations. Data were read, re-read, coded for representations, and then mapped onto the five 
illness representations of the CSM. The full data set was analysed by GE, with a sub-set analysed by 
ED and SH (who collected and analysed the original focus group data).   
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 Findings 
The analysis provided evidence to support the existence of the five illness beliefs among patients 
with PsA, and evidence that these representations affected the way patients engaged with their 
condition. In particular, the evidence found that many participants experienced high levels of 
uncertainty in relation to the identity, time-line, cause, control and consequence of their PsA and its 
treatment. In addition to the five domains of the CSM, the role of external social and environmental 
factors also influenced participants’ illness representations and the way they made sense of their 
PsA. These illness representations appeared to be related to participants’ psychological state, 
including degree of distress. The data were mapped onto the five domains of CSM, using extracts to 
evidence the presence of uncertainty and external factors and how these influenced psychological 
distress and the ways in which participants made sense of their PsA.  
 
Theme 1: Identity 
When discussing the identity of PsA it became apparent that as well as the physical symptoms there 
was an emphasis on the associated psychological distress. This distress was influenced by an 
uncertainty that participants’ perceived regarding the accuracy of their diagnosis, exacerbated by 
the diagnostic difficulties associated with PsA. The uncertainty surrounding the identity appeared to 
stem from a lack of communication between participants’ and clinicians, creating a barrier for 
participants to manage their PsA. 
 
The data suggested that participants were significantly influenced by inter-individual, social factors, 
comparing themselves to others with PsA and members of the general population. When 
comparisons were made they tended to be negative, with participants referring to themselves as 
“inadequate” or not “normal” leading to low mood and depression. The “invisible” nature of the 
symptoms could also induce anxiety, with participants suggesting they felt like a “fraud”. It was also 
highlighted how the general population’s understanding about the potentially disabling impact of 
PsA was often misinformed and inaccurate, possibly due to its invisible nature. This caused some 
participants to experience problems with social participation and work, further contributing to the 
psychological burden of the condition.  
Theme Sub-theme  Quote 
Identity Uncertainty “I'm still not convinced that that's [PsA] what I've got… I'm not sure the 
label's right.” (Mic Pg10 FG5) 
  “I’m still not quite clear why it’s called psoriatic arthritis because I have 
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very little psoriasis so… I’m not quite sure if the diagnosis is right.” (Wil 
Pg5 FG1) 
   “And no one’s actually telling me what the problem is and I can’t deal 
with it, because I don’t know what the problem is.” (Ab Pg30 FG7) 
 External “If anybody saw you they wouldn’t see that [diagnosis] so you feel 
sometimes like you are a fake” (So Pg9 FG2) 
  “People just don’t believe you.  If somebody was to see us now they’d 
say what’s wrong with these guys?” (Sid Pg22 Fg6) 
  “I get called selfish… so I have to constantly explain to my work, my 
wife, my children, my family, my friends why I’m not going out… the 
emotional side of that makes me quite insular” (Ma Pg 22 FG1) 
 
 
Theme 2: Causal 
Participants encountered difficulties and frustrations when it came to identifying the cause of the 
symptoms that they were experiencing. Participants were uncertain which symptoms to attribute to 
their PsA and which to their age, medications or other comorbidities. Adding to the distress was the 
uncertainty that clinicians showed regarding the causality of symptoms. Participants also expressed 
uncertainty about the cause of their PsA as they had lived a healthy lifestyle, suggesting a lack of 
understanding about the condition.  
The lack of understanding from the general population regarding the causes of PsA created another 
barrier for participants in social situations, including negative experiences from members of the 
public who thought that their PsA might be contagious. These encounters caused upset and distress.  
 
Theme Sub-theme  Quote 
Causal Uncertainty “They don’t know what’s causing what…” (Nat Pg13 FG1) 
  “It strikes me that having the two problems [spinal/neurological and 
PsA/rheumatological] and not knowing what is what and how to deal 
with one and how to deal with the other” (Fl Pg31 FG7) 
   “but why should it happen to me when I’ve always looked after myself” 
(Am Pg18 FG8) 
 External “I mean its people look at you and think well you know is it catching, 
that’s the first thing people think… is you know can I get anything from 
that” (PL Pg38 FG4) 
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  “I’ve had customers refusing to deal with me or shake my hand, or 
even use my pen… And it really, really upset me.” (Ab Pg9 FG7) 
 
 
Theme 3: Time-line 
In contrast to the other themes, participants showed certainty and awareness of the long-term and 
progressive nature of PsA, and this was the main source of fear and anxiety surrounding the 
management and prognosis. However, the unpredictable speed and intensity with which PsA might 
progress created uncertainty, although participants understood that clinicians were unable to offer 
predictions. The data also showed how participants’ considered themselves a burden and suggested 
they might have made different decisions if they had known the progression and outcome 
associated with PsA.  
 
Theme Sub-theme  Quote  
Time-line Uncertainty “You worry what’s going to happen next don’t you?  How am I going to 
end up like?” (Al Pg37 FG6) 
 
  “Obviously nobody can tell us that we’re going to be here in five 
years.” (Mar Pg32 FG7) 
 
 External “you’ve got an added anxiety put on you by trying to treat your 
illness… I genuinely wouldn’t have married him, if I’d have known it 




Theme 4: Consequence 
The uncertainty surrounding the consequences of actions associated with PsA was demonstrated to 
be more changeable than other elements of the CSM. Participants explained that in the initial phases 
of diagnosis, a lack of knowledge and understanding about the consequences of PsA led to 
behavioural responses which, with hindsight, were not helpful. Examples include continuing in 
employment and leisure activities which exacerbated the condition. Uncertainty regarding the 
consequences and side effects of taking medications meant that some participants refused, or 
resented taking, pharmacological treatments. This could demonstrate a lack of understanding and 
misinformed illness representations, with potentially negative health outcomes for the patient.  
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The data also highlighted how negative illness representations could affect someone’s ability to take 
in and process information. This might be one explanation for the apparent lack of information 
provided by clinicians.  
 
Theme Sub-theme  Quote 
Identity Uncertainty “I was diagnosed with psoriasis around 16, and being a typical bloke 
ignored it, didn’t take any notice.” (Dar Pg1 FG6) 
  “my big bug bear is the damage caused… also… the lack of alteration 
in my behaviour… I might have stopped mountaineering and marathon 
running if I had known I had arthritis” (Mil Pg4 FG8) 
  “I refused to take Methotrexate… it gives you 99 bad things and one 
good thing.” (Sid Pg23/24 FG6) 
 External “looking back now I was just damn stubborn over it, I wasn’t listening 
to the professionals, and I wish I had done a lot sooner, because it 
[medication] did make a massive difference to me” (Ab Pg19 FG7) 
 
Theme 5: Control  
The management of PsA was a heavily discussed topic throughout all the focus groups, suggesting 
that symptom control and disease management were considered highly important among 
participants. However the focus was on the medical and pharmaceutical management, and once 
again the findings showed significant uncertainty regarding the purpose and effectiveness of 
medications. This uncertainty, similar to Theme 4 (Consequences), was shown to negatively impact 
on adherence. The lack of communication or misunderstanding with clinicians was once again 
highlighted as a major contributor to uncertainty and a potential barrier to disease management; for 
example, participants explained that they were unsure of how to manage their PsA due to 
insufficient information on what the medication was for and how it was working.  Finally, the data 
suggested a gap in PsA management regarding the psychological support available. Several 
participants perceived that the clinician’s focus was only on their physical health while their mental 
health was neglected, and as a consequence they felt alone and at a loss.  
 
Theme Sub-theme  Quote 
Control Uncertainty “I’ve got my doubts as to whether it’s [medication] working because I 
seem to be going backwards” (Ni Pg7 FG4) 
  “If I knew more about the medication then perhaps that would help 
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me. I just don’t understand what the medication is actually doing.” (So 
Pg14 FG2) 
   “I don’t know if mine [medication] is working… they have given it to 
me for a reason but I don’t know what it is supposed to be doing… If I 
knew more about the medication then perhaps that would help me. I 
just don’t understand what the medication is actually doing.” (So Pg14 
FG2) 
 External “I felt very alone in the early days… there was never any information of 
what to look out for, or when you go to here” (Ad Pg15 FG3) 
  “you don’t really know what’s going on.  So it’s just, take that, have 
that.” (St Pg14 FG3) 
  “everything is about your physical symptoms there’s nothing about 
how to deal with the other side of things” [participant referred to 
impact on family life, relationships and emotional states] (Ma Pg24/25 
FG1) 




This study aimed to explore the illness representations of patients with PsA. The findings of this 
study support the five domains of the CSM with data from participants living with PsA fitting the 
framework. Two additional novel findings to emerge in this current analysis are: (i) the high degree 
of uncertainty in relation to participants’ representations; and (ii) the impact of external factors on 
participants’ illness representations. Furthermore the data showed that the uncertainty and the 
external factors were contributing significantly to the psychological burden of PsA experienced by 
participants.  
 
Although physical symptoms were a main feature of the focus group discussions, it was clear that 
the psychological impact of the condition was equally important. This supports previous studies that 
have demonstrated the negative impact psychological distress has on quality of life, mental health 
and coping strategies in patients with PsA [2]. This includes research highlighting how some patients 
with PsA choose to actively avoid or hide from the burden of their condition, with suicide ideation 
being commonly expressed [3]. There is evidence to suggest that illness representations are an 
influential variable impacting on patients’ psychological distress [9]. By supporting patients to 
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become more aware of their illness representations and the techniques they use to evaluate them, 
patients may be able to create more positive coping strategies [6]. Therefore, the finding in the 
current analysis that there is insufficient awareness of psychological impact and associated distress, 
and limited psychological support available, indicates the need for appropriate sign posting or the 
development of services to support the emotional and social needs of people living with PsA.  
One of the main findings, uncertainty, was present throughout the data and within each domain of 
the CSM, often demonstrated by the confusion, misunderstanding and vague responses expressed 
by participants. Uncertainty can be defined as the inability to determine the meaning of illness-
related events and predict outcomes accurately; and it can take the form of ambiguity, complexity, 
lack of or inconsistent information or unpredictability [13]. The ‘Uncertainty in Illness’ theory 
proposes that uncertainty is influenced by the patient, the clinician, and the social environment, and 
exists in situations of ambiguity [13]. Research has established that higher levels of uncertainty are 
related to poorer coping strategies and a greater sense of threat and distress [14]. This is supported 
in our current analysis, which found that the degree of uncertainty surrounding all elements of the 
condition created significant stress and anxiety among participants, impacting negatively on their 
psychological states, coping and physical health.  
 
This uncertainty often appeared to stem from miscommunication and misunderstanding between 
clinicians and patients, which may have contributed to the development of negative illness 
representations and subsequently to poor coping strategies and self-management. The findings 
show that where participants were uncertain as to the diagnosis, outcome of treatment and 
controllability of symptoms, their adherence to treatment regimens was hindered. As suggested by 
Hager et al [7], where illness is perceived as highly symptomatic then chronic avoidance and emotion 
based coping strategies are more likely to be adopted. By contrast, an improved understanding of 
disease management and symptom control can positively impact on psychological states and social 
interaction [7]. 
 
Illness representations and uncertainty are both shaped by an individual’s external social 
environment [7, 13]. The findings of this study highlight how participants were highly influenced by 
the opinions of, and interactions with, friends, family and clinicians, as well as the general 
population. The data showed how several participants felt like a “fraud” and a “burden” on friends 
and family, demonstrating the impact of their perception of other people’s thoughts and feelings 
about them, as well as their own thoughts about their PsA and how the associated restrictions 
affected others. Research in RA has shown that social context has a significant impact on how 
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individuals deal with stress and anxiety [15]. Similar to the findings of this study, Bediako and Friend 
[15] found that the expectations of misinformed family and friends in relation to the patient’s ability 
to function and manage their condition were frequently misaligned with the patient’s own perceived 
capabilities, causing stress and anxiety. 
 
Finally whilst participants’ illness representations can be mapped within the common sense model it 
could be suggested that these specific beliefs are flexible and exist only at the point of assessment as 
illness representations have been shown to be influenced by multiple factors. Few research studies 
have examined illness representations using longitudinal designs, and in this current study data are 
cross sectional. However, participants’ accounts of how their beliefs changed over time suggest the 
potential for illness representations to be flexible rather than stable. There is some evidence from 
other long-term conditions to support this. These changes can start in response to diagnostic results 
and have been associated with emotional distress, recovery, and disability, as well as with 
treatment-related behaviour such as adherence [16]. Thereafter the changes can continue, for 
example research in maintenance hemodialysis found that over a six-year period, patients had fewer 
negative emotional reactions, understood their disease better, considered dialysis more efficient in 
controlling their end stage renal disease, and perceived their illness as having a long-term course 
[17]. Similarly in diabetes, researchers found that patients’ emotional representations decreased 
within two years of diagnosis, whereas illness coherence increased [18]. A six year study in 
osteoarthritis also found that illness representations changed over time, and these changes were 
related to outcome, in particular the progression of disability. Moreover, illness perceptions were 
predictive of disability. This might imply that interventions aimed at changing illness representations 
can contribute to better functional outcome [19]. This has important clinical implications and 
suggests that future research should focus on which illness representations are amenable to change 
in patients with PsA, the timeliness of interventions, and the processes by which helpful changes 
might be facilitated. Finally research has also demonstrated in patients with coronary heart disease 
how over the course of one year quality of life and global health status declined with the disease 
severity and history only accounting for half of the change and illness representations accounting for 
the other [20]. This highlights how an alterable aspect of disease progression, illness 
representations, could be targeted during treatment to reduce the decline in QOL and health status. 
 
Limitations 
This was a secondary analysis of focus group data, which had been collected to explore the issue of 
patient priorities for treatment. Consequently, participants’ illness representations were not 
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specifically or explicitly investigated. If insights into the illness representations of patients with PsA 
had been the aim of the focus groups, researchers would have had the opportunity to elaborate or 
unpick points of interest relating to the CSM. However, it is of interest that the nature and influence 
of illness representations were manifest without being prompted, emphasising their importance in 
how participants were responding to their PsA and its treatment. A further limitation is that focus 
group participants were recruited from the UK only. As participants’ uncertainty appeared, at least in 
part, to be related to information and communication with clinicians, and external factors were also 
an important feature, these findings might have limited transferability in different healthcare 
settings and social and cultural contexts.   
 
Implications  
A greater understanding of the high levels of uncertainty that patients might have about their 
condition and its treatment could provide clinicians with an opportunity to address misinformed or 
erroneous illness representations and ambivalence about treatment. Supporting patients to acquire 
reliable information and express their concerns has the potential to improve quality of life and 
facilitate greater self-management of their PsA. Furthermore, by actively engaging patients in 
discussions regarding their psychological health, including the impact of external factors on their 
wellbeing, clinicians would be able to identify appropriate support pathways and ensure that any 
further referrals that might be needed are made.  
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